Search Login Register

Heparin (Liquaemin) Summary

Description: A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.

Also Known As: Liquaemin; Heparin Sodium; Sodium Heparin; Unfractionated Heparin; Heparin, Sodium; Heparin, Unfractionated; alpha Heparin; Heparinic Acid; alpha-Heparin

Networked: 18766 relevant articles (1275 outcomes, 2327 trials/studies) for this Drug

Key Diseases for which Heparin is Relevant

  1. Thrombosis (Thrombus) : 179 outcomes 221 studies in 2950 results
  2. Hemorrhage : 170 outcomes 309 studies in 2498 results
  3. Venous Thrombosis (Deep-Vein Thrombosis) : 150 outcomes 244 studies in 1472 results
  4. Myocardial Infarction : 90 outcomes 246 studies in 971 results
  5. Thrombocytopenia (Thrombopenia) : 90 outcomes 174 studies in 3572 results
Show All >>

Drugs Related to Heparin

  1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  2. Aspirin (Acetylsalicylic Acid)
  3. Enoxaparin (Lovenox)
  4. bivalirudin (Angiomax)
  5. Thrombin
  6. Warfarin (Coumadin)
  7. Glycoproteins (Glycoprotein)
  8. Heparin (Liquaemin)
  9. Hirudins
  10. Dalteparin (Dalteparin Sodium)
Show All >>

Therapies Related to Heparin

  1. Catheters
  2. Stents
  3. Transplants (Transplant)
  4. Angioplasty (Angioplasty, Transluminal)
  5. Renal Dialysis (Hemodialysis)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.